HCPCS code J7508: Extended-release tacrolimus, per 0.1 mg2026 Medicare rate & RVUs in Maryland
Reports oral Astagraf XL extended-release tacrolimus furnished for transplant rejection prevention, with each unit representing 0.1 mg of drug.
CMS doesn’t publish an office rate for J7508 in Maryland.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J7508 covers
J7508 identifies oral Astagraf XL, an extended-release form of tacrolimus used to help prevent organ rejection in kidney transplant recipients. The patient takes it by mouth, typically as part of a transplant immunosuppression regimen. Transplant clinicians prescribe the medication. This code distinguishes Astagraf XL from immediate-release tacrolimus, other extended-release products, and oral granules.
CMS assigns status E, excluding J7508 from the physician fee schedule. When Medicare covers the drug, payment is under another payment method; the HCPCS pricing method identifies it as a Part B drug generally priced from CMS quarterly Average Sales Price files. Special Medicare coverage instructions apply. Each billing unit represents 0.1 mg, so 1 mg corresponds to 10 units.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J7508 pays more and less in Maryland
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Baltimore area, MD | Unavailable | Unavailable |
| Rest of Maryland | Unavailable | Unavailable |
| Washington, DC area | Unavailable | Unavailable |
How the J7508 rate is calculated
Each of J7508’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J7508
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J7508
J7508 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J7508
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J7508 isn’t priced in this setting.
J7508 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J7503Tacrolimus EREnvarsus XR, per 0.25 mg
- Use J7503 for the Envarsus XR extended-release product. J7508 identifies Astagraf XL; match the code to the product furnished.
- J7507Oral tacrolimusImmediate release, per 1 mg
- J7507 is immediate-release oral tacrolimus with a 1 mg unit. J7508 is extended-release Astagraf XL with a 0.1 mg unit.
- J7521Tacrolimus granulesOral suspension, per 0.1 mg
- J7521 identifies tacrolimus granules for oral suspension. J7508 is for Astagraf XL extended-release tacrolimus.
J7508 billing questions
How many units represent 1 mg of Astagraf XL?
Each unit represents 0.1 mg. A 1 mg amount is 10 units.
How is J7508 different from J7503?
J7508 identifies Astagraf XL extended-release tacrolimus; J7503 identifies the Envarsus XR extended-release product. Select the code matching the product furnished.
How is J7508 different from J7507?
J7508 is for extended-release oral tacrolimus in 0.1 mg units. J7507 identifies immediate-release oral tacrolimus in 1 mg units.
Does J7508 have physician fee schedule payment?
No. CMS assigns status E, excluding it from the physician fee schedule. When covered, it is paid under another method; its HCPCS pricing method identifies it as a Part B drug generally priced from quarterly ASP files.
Does the code identify the transplant visit as well as the drug?
No. J7508 identifies the Astagraf XL drug and its dose unit, not the transplant evaluation or management service. Special Medicare coverage instructions apply to the drug.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J7508 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist